Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, IL1B treatment]

ABSTRACT: We analyzed the differential transcriptional response to IL-1β treatment in cells with experimentally induced hypermethylation of the IL1RN gene promoter.

ORGANISM(S): Homo sapiens

PROVIDER: GSE270873 | GEO | 2025/06/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, transdifferentiation]

Project description:We examine the differential transcriptional dynamics during the C/EBPa-driven transdifferentiation of B-cells into iMacs in cells with experimentally induced hypermethylation of the IL1RN gene promoter.

2025-06-02 | GSE270876 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [DNA methylation arrays]

Project description:We assessed both on-target and off-target DNA methylation editing events following targeting with dCas9-DNMT3A to the IL1RN locus in cells undergoing B to macrophage transdifferentiation.

2025-06-02 | GSE268284 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [dCas9-DNMT3A ChIP-seq]

Project description:To investigate the genome-wide occupancy of the DNA methylation editing tool dCas9-DNMT3A in cells harboring non-targeting sgRNAs (CTRL) and cells harboring sgRNAs targeting the IL1RN promoter (sgIL1RN).

2025-06-02 | GSE270885 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-06-02 | GSE271842 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [WGBS-seq]

Project description:We investigated the genome-wide DNA methylation dynamics occurring during the C/EBPa-driven B cell to macrophage transdifferentiation.

2025-06-02 | GSE270886 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, IL1B treatment]

Project description:Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, IL1B treatment]

| PRJNA1128672 | ENA

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

Project description:Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

| PRJNA1133726 | ENA

RNA-seq of BM neutrophils after treated with IL1b/IL6/PGE2

Project description:To investigate the effects of IL-1β/IL-6/PGE2 on neutrophil modulation, we performed RNA-seq to compare IL-1β/IL-6/PGE2-treated neutrophils to vehicle-treated neutrophils.

2022-12-12 | E-MTAB-12367 | biostudies-arrayexpress

IL1B Fibrosis Secretome Samples

Project description:Our results identify IL-1β induced immune-competency in human cardiac fibroblasts and suggest that fibroblast secretome modulation may constitute a therapeutic approach to PAH and other diseases typified by inflammation and fibrotic remodeling.

2024-01-26 | PXD044147 | Pride

Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides.

Project description:Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) has revolutionized genome editing and has great potential for many applications, such as correcting human genetic disorders. To increase the safety of genome editing applications, CRISPR-Cas may benefit from strict control over Cas enzyme activity. Previously, anti-CRISPR proteins and designed oligonucleotides have been proposed to modulate CRISPR-Cas activity. In this study, we report on the potential of guide-complementary DNA oligonucleotides as controlled inhibitors of Cas9 ribonucleoprotein complexes. First, we show that DNA oligonucleotides inhibit Cas9 activity in human cells, reducing both on- and off-target cleavage. We then used in vitro assays to better understand how inhibition is achieved and under which conditions. Two factors were found to be important for robust inhibition: the length of the complementary region and the presence of a protospacer adjacent motif-loop on the inhibitor. We conclude that DNA oligonucleotides can be used to effectively inhibit Cas9 activity both ex vivo and in vitro.

| S-EPMC9419950 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data